Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$170.78 - $208.42 $10,417 - $12,713
-61 Reduced 2.64%
2,249 $414,000
Q4 2023

Feb 07, 2024

SELL
$114.17 - $185.35 $562,173 - $912,663
-4,924 Reduced 68.07%
2,310 $415,000
Q3 2023

Nov 08, 2023

SELL
$138.78 - $176.51 $1,249 - $1,588
-9 Reduced 0.12%
7,234 $1.15 Million
Q2 2023

Jul 26, 2023

BUY
$138.42 - $180.31 $96,478 - $125,676
697 Added 10.65%
7,243 $1.03 Million
Q1 2023

Apr 28, 2023

BUY
$154.26 - $198.1 $134,668 - $172,941
873 Added 15.39%
6,546 $1.1 Million
Q4 2022

Feb 01, 2023

SELL
$162.42 - $220.56 $19,165 - $26,026
-118 Reduced 2.04%
5,673 $960,000
Q3 2022

Oct 25, 2022

SELL
$160.42 - $256.21 $2,245 - $3,586
-14 Reduced 0.24%
5,791 $1.08 Million
Q2 2022

Aug 03, 2022

SELL
$140.68 - $188.02 $114,372 - $152,860
-813 Reduced 12.28%
5,805 $960,000
Q1 2022

May 04, 2022

BUY
$161.19 - $257.96 $89,944 - $143,941
558 Added 9.21%
6,618 $1.25 Million
Q4 2021

Jan 27, 2022

BUY
$247.59 - $304.47 $20,797 - $25,575
84 Added 1.41%
6,060 $1.61 Million
Q3 2021

Oct 29, 2021

BUY
$194.77 - $324.21 $129,716 - $215,923
666 Added 12.54%
5,976 $1.73 Million
Q2 2021

Jul 26, 2021

BUY
$165.87 - $220.95 $202,195 - $269,338
1,219 Added 29.8%
5,310 $1.06 Million
Q1 2021

Apr 27, 2021

SELL
$180.37 - $226.26 $219,690 - $275,584
-1,218 Reduced 22.94%
4,091 $795,000
Q4 2020

Jan 25, 2021

BUY
$148.08 - $206.57 $398,187 - $555,466
2,689 Added 102.63%
5,309 $1.02 Million
Q3 2020

Nov 06, 2020

SELL
$122.51 - $158.27 $39,570 - $51,121
-323 Reduced 10.98%
2,620 $387,000
Q2 2020

Jul 23, 2020

BUY
$94.33 - $140.48 $29,996 - $44,672
318 Added 12.11%
2,943 $364,000
Q1 2020

Apr 30, 2020

BUY
$84.96 - $109.14 $15,802 - $20,300
186 Added 7.63%
2,625 $253,000
Q4 2019

Jan 21, 2020

BUY
$73.84 - $93.08 $180,095 - $227,022
2,439 New
2,439 $226,000
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $457,144 - $546,942
-14,053 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$36.98 - $46.06 $519,679 - $647,281
14,053
14,053 $539,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.15B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.